View ValuationPoly Xverse Intelligent Technology 将来の成長Future 基準チェック /06現在、 Poly Xverse Intelligent Technologyの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Leisure 収益成長17.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 01Poly Xverse Intelligent Technology Co. Ltd, Annual General Meeting, Jun 25, 2026Poly Xverse Intelligent Technology Co. Ltd, Annual General Meeting, Jun 25, 2026, at 10:30 China Standard Time. Location: rooms 1101-4, 11/f, harcourt house, 39 gloucester road, wanchai, Hong KongBoard Change • May 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Jade Wong is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Mar 30Full year 2025 earnings released: HK$0.42 loss per share (vs HK$0.56 loss in FY 2024)Full year 2025 results: HK$0.42 loss per share. Revenue: HK$382.4m (down 26% from FY 2024). Net loss: HK$92.8m (loss widened 27% from FY 2024).お知らせ • Mar 17Winshine Science Company Limited to Report Fiscal Year 2025 Results on Mar 27, 2026Winshine Science Company Limited announced that they will report fiscal year 2025 results on Mar 27, 2026分析記事 • Jan 21Winshine Science Company Limited (HKG:209) Stock Rockets 45% As Investors Are Less Pessimistic Than ExpectedThe Winshine Science Company Limited ( HKG:209 ) share price has done very well over the last month, posting an...New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 9x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-HK$175m). Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Minor Risk Market cap is less than US$100m (HK$271.9m market cap, or US$34.9m).分析記事 • Nov 05Winshine Science Company Limited's (HKG:209) Price Is Right But Growth Is Lacking After Shares Rocket 61%Winshine Science Company Limited ( HKG:209 ) shareholders have had their patience rewarded with a 61% share price jump...Board Change • Nov 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Shaopeng Lin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Oct 20Winshine Science Company Limited Announces Company Secretary Changes, Effective October 17, 2025Winshine Science Company Limited hereby announces that, with effect from October 17, 2025, Ms. Yu Nga Yan resigned as the company secretary of the Company and ceased to be an authorised representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and an authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong); and Ms. Chan Yuk Yee has been appointed as the Company Secretary and an authorised representative under Rule 3.05 of the Listing Rules and an authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). Ms. Chan, aged 57, holds a Master of Business Law degree from Monash University in Australia and is a Chartered Secretary, Chartered Governance Professional and an associate of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom. She has extensive experience in corporate governance and company secretarial practice. Before joining the Company, Ms. Chan served as company secretary at several listed companies in Hong Kong.お知らせ • Oct 15Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 181.994796 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 181.994796 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,299,962,832 Price\Range: HKD 0.14 Discount Per Security: HKD 0.0035 Transaction Features: Rights OfferingReported Earnings • Oct 02First half 2025 earnings released: HK$0.25 loss per share (vs HK$0.22 loss in 1H 2024)First half 2025 results: HK$0.25 loss per share (further deteriorated from HK$0.22 loss in 1H 2024). Revenue: HK$148.4m (down 22% from 1H 2024). Net loss: HK$38.3m (loss widened 44% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.New Risk • Sep 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 28% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (74% average weekly change). Negative equity (-HK$175m). Market cap is less than US$10m (HK$52.0m market cap, or US$6.69m). Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Significant insider selling over the past 3 months (HK$45m sold).お知らせ • Sep 12Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 10.833024 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 10.833024 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 30,951,496 Price\Range: HKD 0.35 Discount Per Security: HKD 0.00875 Transaction Features: Subsequent Direct ListingRecent Insider Transactions • Sep 06Insider recently bought HK$19m worth of stockOn the 3rd of September, Jingyu Wang bought around 37m shares on-market at roughly HK$0.50 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought HK$14m more in shares than they have sold in the last 12 months.Reported Earnings • Sep 02First half 2025 earnings released: HK$0.25 loss per share (vs HK$0.22 loss in 1H 2024)First half 2025 results: HK$0.25 loss per share (further deteriorated from HK$0.22 loss in 1H 2024). Revenue: HK$148.4m (down 22% from 1H 2024). Net loss: HK$38.3m (loss widened 44% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -HK$37m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-HK$37m free cash flow). Share price has been highly volatile over the past 3 months (74% average weekly change). Negative equity (-HK$175m). Minor Risks Significant insider selling over the past 3 months (HK$4.5m sold). Market cap is less than US$100m (HK$85.1m market cap, or US$10.9m).お知らせ • Aug 15Winshine Science Company Limited to Report First Half, 2025 Results on Aug 29, 2025Winshine Science Company Limited announced that they will report first half, 2025 results on Aug 29, 2025分析記事 • Aug 14Winshine Science Company Limited (HKG:209) Shares Fly 186% But Investors Aren't Buying For GrowthDespite an already strong run, Winshine Science Company Limited ( HKG:209 ) shares have been powering on, with a gain...New Risk • Aug 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 69% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (69% average weekly change). Negative equity (-HK$140m). Minor Risks Shareholders have been diluted in the past year (26% increase in shares outstanding). Market cap is less than US$100m (HK$116.1m market cap, or US$14.8m).Board Change • Aug 11Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Jul 09Winshine Science Company Limited Announces Change of Company SecretaryThe board of directors of Winshine Science Company Limited announced that Mr. Lam Koon Fai ("Mr. Lam") has tendered his resignation as the company secretary (the "Company Secretary") and an authorised representative of the Company to pursue other career development with effect from 7 July 2025. Mr. Lam confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that Ms. Yu Nga Yan ("Ms. Yu") has been appointed as the Company Secretary and an authorised representative of the Company with effect from 7 July 2025. Ms. Yu has over 10 years of auditing, accounting and company secretarial practice in listed companies on the Stock Exchange. Ms. Yu served as a senior associate in audit department in Deloitte Touche Tohmatsu from 2007 to 2012. Ms. Yu joined YTO International Express and Supply Chain Technology Limited, the issued shares of which are listed on the Main Board of the Stock Exchange (stock code: 6123) in 2012 and served as the group financial controller from January 2020 to July 2021. Ms. Yu obtained a bachelor's degree of business administration in accounting from the Hong Kong University of Science and Technology. Ms. Yu is a member of The Hong Kong Institute of Certified Public Accountants.Board Change • Jun 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 22Winshine Science Company Limited Announces Retirement of Mr. Zhao Yong as Independent Non-Executive Director, Effective Date Is May 22, 2025Winshine Science Company Limited announced that the resolution regarding the re-election of Mr. Zhao Yong as an independent non-executive Director was not passed at the AGM. Consequently, Mr. Zhao has retired as an independent non-executive Director, effective from the conclusion of the AGM on May 22, 2025. Following his retirement, Mr. Zhao ceased to be a member of both the audit committee and the remuneration committee of the Company. The composition of the board committees upon his retirement is as follows: Audit Committee - Mr. Kwok Kim Hung Eddie (Chairman), Ms. Wang Yumei; Remuneration Committee - Mr. Weng Zudian (Chairman), Ms. Wang Yumei; Nomination Committee - Mr. Jiang Qinghui (Chairman), Mr. Kwok Kim Hung Eddie, Ms. Wang Yumei.Board Change • May 06Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 30Winshine Science Company Limited, Annual General Meeting, May 22, 2025Winshine Science Company Limited, Annual General Meeting, May 22, 2025, at 10:30 China Standard Time. Location: 35/f, dah sing financial centre, 248 queen`s road east, wanchai, Hong KongBoard Change • Apr 07Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 02Full year 2024 earnings released: HK$0.56 loss per share (vs HK$0.32 loss in FY 2023)Full year 2024 results: HK$0.56 loss per share (further deteriorated from HK$0.32 loss in FY 2023). Revenue: HK$515.9m (down 1.4% from FY 2023). Net loss: HK$73.0m (loss widened 155% from FY 2023). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.お知らせ • Mar 14Winshine Science Company Limited to Report Fiscal Year 2024 Results on Mar 31, 2025Winshine Science Company Limited announced that they will report fiscal year 2024 results on Mar 31, 2025Board Change • Mar 03Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Feb 28Winshine Science Company Limited Announces Board and Committee ChangesThe board of directors of Winshine Science Company Limited announced that, with effect from 28 February 2025, Mr. Chan Cheuk Ho (Mr. Chan) resigned as an independent non-executive Director (the "INED") due to his desire to devote more time to his personal and other business engagements. Following his resignation as a Director, the Board further announce that, with effect from 28 February 2025: Audit Committee: Mr. Chan has ceased to be the chairman of the audit committee and Mr. Kwok Kim Hung Eddie, the existing INED, has been redesignated as the chairman of the audit committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the audit committee. Remuneration Committee: Mr. Chan has ceased to be the chairman of the remuneration committee and Mr. Weng Zudian, the existing executive director, has been redesignated as the chairman of the remuneration committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the remuneration committee. Nomination Committee: Mr. Chan has ceased to be a member of the nomination committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the nomination committee.Board Change • Feb 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Yumei Wang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 29Winshine Science Company Limited has completed a Follow-on Equity Offering in the amount of HKD 1.316 million.Winshine Science Company Limited has completed a Follow-on Equity Offering in the amount of HKD 1.316 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,400,000 Price\Range: HKD 0.14 Transaction Features: Subsequent Direct Listingお知らせ • Jan 23Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 1.316 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 1.316 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,400,000 Price\Range: HKD 0.14 Transaction Features: Subsequent Direct ListingBoard Change • Jan 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Yumei Wang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Dec 12Winshine Science Company Limited Appoints Wang Yumei as Independent Non-Executive DirectorThe board of directors of Winshine Science Company Limited announced that Ms. Wang Yumei ("Ms. Wang") has been appointed as an independent non-executive Director with effect from 12 December 2024. Ms. Wang, aged 42, has been acting as the deputy chief lawyer and one of the founders of Hebei Shoudao Law Firm. She has over 15 years of experience in the legal and business practice of in the PRC, including provision of annual legal retainer service for both government agencies and enterprise units. Ms. Wang graduated from Hebei GEO University majoring in Laws and obtained a Master of Laws from Hebei University in the PRC. Pursuant to the letter of appointment entered into between the Company and Ms. Wang, she has been appointed for a term of two years commencing from 12 December 2024 and is subject to the provision of retirement by rotation and re-election at the annual general meeting of the Company at least once every three years in accordance with the articles of association of the Company.お知らせ • Aug 17Winshine Science Company Limited to Report First Half, 2024 Results on Aug 30, 2024Winshine Science Company Limited announced that they will report first half, 2024 results on Aug 30, 2024Board Change • May 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Cheuk Ho Chan was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Poly Xverse Intelligent Technology は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SEHK:209 - アナリストの将来予測と過去の財務データ ( )HKD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025382-93-11-7N/A9/30/2025428-891822N/A6/30/2025473-854651N/A3/31/2025495-79412N/A12/31/2024516-73-37-28N/A9/30/2024514-54-120N/A6/30/2024512-341327N/A3/31/2024517-31518N/A12/31/2023523-29-49N/A9/30/2023539-27-47-37N/A6/30/2023555-26-90-83N/A3/31/2023702-9-33-24N/A12/31/202284982535N/A9/30/2022904-421121N/A6/30/2022958-92-38N/A3/31/2022841-114-14-4N/A12/31/2021725-136-25-15N/A9/30/2021620-113-11-3N/A6/30/2021516-9038N/A3/31/2021440-93-26-20N/A12/31/2020364-96-55-49N/A9/30/2020480-67-14-6N/A6/30/2020596-382738N/A3/31/2020623-401629N/A12/31/2019649-42521N/A9/30/2019583-112N/A-47N/A6/30/2019516-182N/A-115N/A3/31/2019576-168N/A-86N/A12/31/2018637-154N/A-58N/A9/30/2018668-104N/A-29N/A6/30/2018700-54N/A1N/A3/31/2018645-66N/A-12N/A12/31/2017590-78N/A-25N/A9/30/2017468-94N/A-24N/A6/30/2017345-110N/A-22N/A3/31/2017291-169N/A-13N/A12/31/2016236-227N/A-3N/A9/30/2016240-211N/A-78N/A6/30/2016243-194N/A-153N/A3/31/2016245-164N/A-229N/A12/31/2015248-133N/A-306N/A9/30/2015317-155N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 209の予測収益成長が 貯蓄率 ( 3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 209の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 209の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 209の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 209の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 209の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YConsumer-durables 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/14 04:58終値2026/07/14 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Poly Xverse Intelligent Technology Co. Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 01Poly Xverse Intelligent Technology Co. Ltd, Annual General Meeting, Jun 25, 2026Poly Xverse Intelligent Technology Co. Ltd, Annual General Meeting, Jun 25, 2026, at 10:30 China Standard Time. Location: rooms 1101-4, 11/f, harcourt house, 39 gloucester road, wanchai, Hong Kong
Board Change • May 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Jade Wong is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Mar 30Full year 2025 earnings released: HK$0.42 loss per share (vs HK$0.56 loss in FY 2024)Full year 2025 results: HK$0.42 loss per share. Revenue: HK$382.4m (down 26% from FY 2024). Net loss: HK$92.8m (loss widened 27% from FY 2024).
お知らせ • Mar 17Winshine Science Company Limited to Report Fiscal Year 2025 Results on Mar 27, 2026Winshine Science Company Limited announced that they will report fiscal year 2025 results on Mar 27, 2026
分析記事 • Jan 21Winshine Science Company Limited (HKG:209) Stock Rockets 45% As Investors Are Less Pessimistic Than ExpectedThe Winshine Science Company Limited ( HKG:209 ) share price has done very well over the last month, posting an...
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 9x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-HK$175m). Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Minor Risk Market cap is less than US$100m (HK$271.9m market cap, or US$34.9m).
分析記事 • Nov 05Winshine Science Company Limited's (HKG:209) Price Is Right But Growth Is Lacking After Shares Rocket 61%Winshine Science Company Limited ( HKG:209 ) shareholders have had their patience rewarded with a 61% share price jump...
Board Change • Nov 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Shaopeng Lin is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Oct 20Winshine Science Company Limited Announces Company Secretary Changes, Effective October 17, 2025Winshine Science Company Limited hereby announces that, with effect from October 17, 2025, Ms. Yu Nga Yan resigned as the company secretary of the Company and ceased to be an authorised representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and an authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong); and Ms. Chan Yuk Yee has been appointed as the Company Secretary and an authorised representative under Rule 3.05 of the Listing Rules and an authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). Ms. Chan, aged 57, holds a Master of Business Law degree from Monash University in Australia and is a Chartered Secretary, Chartered Governance Professional and an associate of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom. She has extensive experience in corporate governance and company secretarial practice. Before joining the Company, Ms. Chan served as company secretary at several listed companies in Hong Kong.
お知らせ • Oct 15Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 181.994796 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 181.994796 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,299,962,832 Price\Range: HKD 0.14 Discount Per Security: HKD 0.0035 Transaction Features: Rights Offering
Reported Earnings • Oct 02First half 2025 earnings released: HK$0.25 loss per share (vs HK$0.22 loss in 1H 2024)First half 2025 results: HK$0.25 loss per share (further deteriorated from HK$0.22 loss in 1H 2024). Revenue: HK$148.4m (down 22% from 1H 2024). Net loss: HK$38.3m (loss widened 44% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
New Risk • Sep 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 28% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (74% average weekly change). Negative equity (-HK$175m). Market cap is less than US$10m (HK$52.0m market cap, or US$6.69m). Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Significant insider selling over the past 3 months (HK$45m sold).
お知らせ • Sep 12Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 10.833024 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 10.833024 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 30,951,496 Price\Range: HKD 0.35 Discount Per Security: HKD 0.00875 Transaction Features: Subsequent Direct Listing
Recent Insider Transactions • Sep 06Insider recently bought HK$19m worth of stockOn the 3rd of September, Jingyu Wang bought around 37m shares on-market at roughly HK$0.50 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought HK$14m more in shares than they have sold in the last 12 months.
Reported Earnings • Sep 02First half 2025 earnings released: HK$0.25 loss per share (vs HK$0.22 loss in 1H 2024)First half 2025 results: HK$0.25 loss per share (further deteriorated from HK$0.22 loss in 1H 2024). Revenue: HK$148.4m (down 22% from 1H 2024). Net loss: HK$38.3m (loss widened 44% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -HK$37m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-HK$37m free cash flow). Share price has been highly volatile over the past 3 months (74% average weekly change). Negative equity (-HK$175m). Minor Risks Significant insider selling over the past 3 months (HK$4.5m sold). Market cap is less than US$100m (HK$85.1m market cap, or US$10.9m).
お知らせ • Aug 15Winshine Science Company Limited to Report First Half, 2025 Results on Aug 29, 2025Winshine Science Company Limited announced that they will report first half, 2025 results on Aug 29, 2025
分析記事 • Aug 14Winshine Science Company Limited (HKG:209) Shares Fly 186% But Investors Aren't Buying For GrowthDespite an already strong run, Winshine Science Company Limited ( HKG:209 ) shares have been powering on, with a gain...
New Risk • Aug 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 69% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (69% average weekly change). Negative equity (-HK$140m). Minor Risks Shareholders have been diluted in the past year (26% increase in shares outstanding). Market cap is less than US$100m (HK$116.1m market cap, or US$14.8m).
Board Change • Aug 11Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Jul 09Winshine Science Company Limited Announces Change of Company SecretaryThe board of directors of Winshine Science Company Limited announced that Mr. Lam Koon Fai ("Mr. Lam") has tendered his resignation as the company secretary (the "Company Secretary") and an authorised representative of the Company to pursue other career development with effect from 7 July 2025. Mr. Lam confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that Ms. Yu Nga Yan ("Ms. Yu") has been appointed as the Company Secretary and an authorised representative of the Company with effect from 7 July 2025. Ms. Yu has over 10 years of auditing, accounting and company secretarial practice in listed companies on the Stock Exchange. Ms. Yu served as a senior associate in audit department in Deloitte Touche Tohmatsu from 2007 to 2012. Ms. Yu joined YTO International Express and Supply Chain Technology Limited, the issued shares of which are listed on the Main Board of the Stock Exchange (stock code: 6123) in 2012 and served as the group financial controller from January 2020 to July 2021. Ms. Yu obtained a bachelor's degree of business administration in accounting from the Hong Kong University of Science and Technology. Ms. Yu is a member of The Hong Kong Institute of Certified Public Accountants.
Board Change • Jun 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 22Winshine Science Company Limited Announces Retirement of Mr. Zhao Yong as Independent Non-Executive Director, Effective Date Is May 22, 2025Winshine Science Company Limited announced that the resolution regarding the re-election of Mr. Zhao Yong as an independent non-executive Director was not passed at the AGM. Consequently, Mr. Zhao has retired as an independent non-executive Director, effective from the conclusion of the AGM on May 22, 2025. Following his retirement, Mr. Zhao ceased to be a member of both the audit committee and the remuneration committee of the Company. The composition of the board committees upon his retirement is as follows: Audit Committee - Mr. Kwok Kim Hung Eddie (Chairman), Ms. Wang Yumei; Remuneration Committee - Mr. Weng Zudian (Chairman), Ms. Wang Yumei; Nomination Committee - Mr. Jiang Qinghui (Chairman), Mr. Kwok Kim Hung Eddie, Ms. Wang Yumei.
Board Change • May 06Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 30Winshine Science Company Limited, Annual General Meeting, May 22, 2025Winshine Science Company Limited, Annual General Meeting, May 22, 2025, at 10:30 China Standard Time. Location: 35/f, dah sing financial centre, 248 queen`s road east, wanchai, Hong Kong
Board Change • Apr 07Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 02Full year 2024 earnings released: HK$0.56 loss per share (vs HK$0.32 loss in FY 2023)Full year 2024 results: HK$0.56 loss per share (further deteriorated from HK$0.32 loss in FY 2023). Revenue: HK$515.9m (down 1.4% from FY 2023). Net loss: HK$73.0m (loss widened 155% from FY 2023). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.
お知らせ • Mar 14Winshine Science Company Limited to Report Fiscal Year 2024 Results on Mar 31, 2025Winshine Science Company Limited announced that they will report fiscal year 2024 results on Mar 31, 2025
Board Change • Mar 03Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Yumei Wang was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 28Winshine Science Company Limited Announces Board and Committee ChangesThe board of directors of Winshine Science Company Limited announced that, with effect from 28 February 2025, Mr. Chan Cheuk Ho (Mr. Chan) resigned as an independent non-executive Director (the "INED") due to his desire to devote more time to his personal and other business engagements. Following his resignation as a Director, the Board further announce that, with effect from 28 February 2025: Audit Committee: Mr. Chan has ceased to be the chairman of the audit committee and Mr. Kwok Kim Hung Eddie, the existing INED, has been redesignated as the chairman of the audit committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the audit committee. Remuneration Committee: Mr. Chan has ceased to be the chairman of the remuneration committee and Mr. Weng Zudian, the existing executive director, has been redesignated as the chairman of the remuneration committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the remuneration committee. Nomination Committee: Mr. Chan has ceased to be a member of the nomination committee and Ms. Wang Yumei, the existing INED, has been appointed as a member of the nomination committee.
Board Change • Feb 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Yumei Wang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 29Winshine Science Company Limited has completed a Follow-on Equity Offering in the amount of HKD 1.316 million.Winshine Science Company Limited has completed a Follow-on Equity Offering in the amount of HKD 1.316 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,400,000 Price\Range: HKD 0.14 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 23Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 1.316 million.Winshine Science Company Limited has filed a Follow-on Equity Offering in the amount of HKD 1.316 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,400,000 Price\Range: HKD 0.14 Transaction Features: Subsequent Direct Listing
Board Change • Jan 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Yumei Wang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 12Winshine Science Company Limited Appoints Wang Yumei as Independent Non-Executive DirectorThe board of directors of Winshine Science Company Limited announced that Ms. Wang Yumei ("Ms. Wang") has been appointed as an independent non-executive Director with effect from 12 December 2024. Ms. Wang, aged 42, has been acting as the deputy chief lawyer and one of the founders of Hebei Shoudao Law Firm. She has over 15 years of experience in the legal and business practice of in the PRC, including provision of annual legal retainer service for both government agencies and enterprise units. Ms. Wang graduated from Hebei GEO University majoring in Laws and obtained a Master of Laws from Hebei University in the PRC. Pursuant to the letter of appointment entered into between the Company and Ms. Wang, she has been appointed for a term of two years commencing from 12 December 2024 and is subject to the provision of retirement by rotation and re-election at the annual general meeting of the Company at least once every three years in accordance with the articles of association of the Company.
お知らせ • Aug 17Winshine Science Company Limited to Report First Half, 2024 Results on Aug 30, 2024Winshine Science Company Limited announced that they will report first half, 2024 results on Aug 30, 2024
Board Change • May 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Cheuk Ho Chan was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.